Capstone Investment Advisors »

Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Capstone Investment Advisors

Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Capstone Investment Advisors from 13F filings

Historical chart of Capstone Investment Advisors investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Capstone Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Capstone Investment Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $12M 13M 0.94
2023-12-31 $17M 18M 0.99
2023-09-30 $9.3M 10M 0.93

More positions owned by Capstone Investment Advisors

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation Put Option (NVDA)
Microsoft Corporation Put Option (MSFT)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Meta Platforms Cl A Put Option (META)
Amazon Call Option (AMZN)
Apple Put Option (AAPL)
Tesla Motors Put Option (TSLA)
Ishares Tr Msci Emg Mkt Etf Put Option (EEM)
Select Sector Spdr Tr Financial Call Option (XLF)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Alphabet Cap Stk Cl C Call Option (GOOG)
Broadcom (AVGO)

View all positions for Capstone Investment Advisors

Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1

Ubs Global Asset Management Americas
Readystate Asset Management
Calamos Advisors
Steelhead Partners
Aequim Alternative Investments
Davidson Kempner Capital Management
Wolverine Asset Management
Lazard Asset Management
Zazove Associates
Shenkman Capital Management
CNH Partners
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Capstone Investment Advisors
Citadel Advisors
MacKay Shields

View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1